Imatinib mesylate is a tyrosine kinase inhibitor used in the treatment of cancers including chronic myeloid leukemia. In their study, however, Kerkelä et al. report that this drug can be ...

Final draft guidance published today proposes to recommend Novartis' Glivec (imatinib) for up to three years for people who have had a gastro-intestinal stromal tumour (GIST) removed and who are ...